Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Fibrauretine sustained-release dropping pills and preparation method thereof

A technology of sustained-release dripping pills and dripping pills, which is applied in the direction of pharmaceutical formulas, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., and can solve the problem that the clinical use of injection preparations is not as convenient, stable and safe as oral preparations The sexiness is not as good as oral preparations, and the dissolution process is prone to stickiness and other problems, so as to achieve the effect of improving bioavailability, low price, and not easy to hydrolyze

Inactive Publication Date: 2008-09-24
北京博智绿洲医药科技有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The preparations made of palmetine include palmatine tablets, palmetine injection, etc. Although they have been used in a large number of clinical applications since they were launched, they have achieved good therapeutic effects. The dissolution rate in medium is slow, stickiness and agglomeration are prone to occur during the dissolution process, and redissolution is difficult. Oral preparations such as tablets are slowly absorbed in the digestive tract due to the large molecular weight of the active ingredient, and their bioavailability is low. Injection preparations It is not as convenient as oral preparations in clinical use, especially the stability and safety of traditional Chinese medicine injections are not as good as oral preparations, and quality problems such as crystallization or precipitation often occur

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] Now with several groups of specific examples, the preparation method of the padatine sustained-release dripping pills of the present invention will be further described.

[0028] First group:

[0029] Based on the total weight of 100g, weigh 30% of the matrix PEG4000, 20% of PEG6000, 5% of PEG10000, 20% of stearic acid, 10% of glycerol monostearate, and 15% of raw material palmatine; place the matrix in a heating container Heating and stirring to make it melt, add corresponding proportion of palmatine, fully stir, under the condition of heat preservation, drop the melted or mixed medicine solution into the condensation column filled with simethicone oil, wherein, when heated and melted The temperature of the condensate is 60°C, the temperature of the upper part of the condensate is 20°C, and the temperature of the bottom is 0°C; take it out after forming.

[0030] The obtained product has a 2-hour cumulative release percentage of 41-52%, a 6-hour cumulative release per...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a fibrauretine sustained-release pill having the antibacterial and antiphlogistic action as well as a preparation method thereof. The invention aims at providing a medicine(the fibrauretine sustained-release pill) which takes fibrauretine as effective constituent and has the antibacterial and antiphlogistic action; compared with the existing oral preparation at the market, the pill has the advantages that: 1. the deficiency of the existing oral pharmaceutical preparation is made up and a pill preparation which has high bioavailability and rapid effect is provided; 2. after being made into the sustained-release pill, the medication content is high, the medicine release is controllable, the time of taking the medicine by the patient is few, the medicine taking is convenient, the price is low; 3. the production equipment is simple and no pollution is generated in the production. The fibrauretine sustained-release pill related by the invention takes the fibrauretine which is the effective constituent of calamus margaritae of traditional Chinese medicine as raw material and can be prepared together with medicated carrier that takes hydrophilic framework material and hydrophobic framework material as stroma.

Description

technical field [0001] The invention belongs to the technical field of medicines, and relates to a palmatine sustained-release dripping pill with antibacterial and anti-inflammatory effects and a preparation method thereof. Background technique [0002] Huangteng, also known as Huanglian, Rhubarb, is the root and stem of Huangteng, a plant of the family Fangjiaceae. Cold in nature, sweet in taste, bitter in taste, poisonous, enters the two meridians of the heart and liver. "Compendium of Materia Medica" records "Huangteng, born in Lingnan. It looks like self-defense. The natives often take this vine, and even if they eat poisonous food, they will naturally not hair." Detumescence. Control heat depression, constipation, dysentery, stone water, sore carbuncle, petechiae, red eyes." "Guangxi Chinese Herbal Medicine" said "clearing heart-fire, diuresis. Treatment of dysentery, acute gastroenteritis, acute tonsillitis, pharyngitis , conjunctivitis, tuberculosis, sores, boils, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/22A61K31/4745A61K47/34A61P31/04A61K47/10
Inventor 曲韵智
Owner 北京博智绿洲医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products